[A case of Creutzfeldt-Jakob disease with codon 129 polymorphism and codon 180 point mutation]

Kazunari Suzuki1, Noriaki Matsumura, Tatsuya Suzuki

  • 1Division of Geriatric Medicine, Nippon Medical School.

Insights

This study details a rare case of Creutzfeldt-Jakob disease (CJD) in a Japanese man with a unique prion protein gene mutation. The patient initially misdiagnosed with Alzheimer's disease highlights diagnostic challenges in rare neurological disorders.

Area of Science:

  • Neurology
  • Genetics
  • Pathology

Background:

  • Creutzfeldt-Jakob disease (CJD) is a rare, fatal neurodegenerative prion disease.
  • Genetic mutations in the prion protein (PrP) gene are associated with CJD.
  • Diagnostic challenges exist, especially in atypical presentations.

Observation:

  • A 79-year-old Japanese man presented with rapidly progressing neurological decline.
  • Initial diagnosis was Alzheimer's disease with cerebrovascular disease based on SPECT imaging.
  • Electroencephalogram did not show characteristic periodic synchronous discharges.

Findings:

  • Prion protein gene analysis revealed a combination of codon 129 polymorphism (Met/Val) and codon 180 point mutation (Val/Ile).
  • Autopsy confirmed spongiform changes and senile plaques in the cerebral cortex.
  • The hippocampus and cerebellar cortex were preserved, with no lacunar infarctions.

Implications:

  • This case highlights the diagnostic difficulty of CJD, particularly with co-occurring genetic variations.
  • The specific PrP gene mutation combination (codon 180 and 129) is rarely reported, adding to the understanding of CJD's genetic landscape.
  • Further research into genotype-phenotype correlations in CJD is warranted for improved diagnosis and management.

Related Concept Videos

Point and Frameshift Mutations01:30

Point and Frameshift Mutations

Point mutations are genetic alterations involving the change of a single nucleotide base pair in DNA. Depending on how the alteration affects protein synthesis, they can lead to various consequences.Point mutations fall into the following types:Silent mutations occur when a nucleotide change does not alter the amino acid sequence due to the redundancy of the genetic code. For instance, changing ACC to ACA still encodes threonine, leaving the protein function unaffected. This occurs because...
Translation01:31

Translation

Lesson: Translation
Translation is the process of synthesizing proteins from the genetic information carried by messenger RNA (mRNA). Following transcription, it constitutes the final step in the expression of genes. This process is carried out by ribosomes, complexes of protein and specialized RNA molecules. Ribosomes, transfer RNA (tRNA), and other proteins produce a chain of amino acids—the polypeptide—as the end product of translation.
Translation Produces the Building Blocks of Life
Translation01:31

Translation

Lesson: Translation
Translation is the process of synthesizing proteins from the genetic information carried by messenger RNA (mRNA). Following transcription, it constitutes the final step in the expression of genes. This process is carried out by ribosomes, complexes of protein and specialized RNA molecules. Ribosomes, transfer RNA (tRNA), and other proteins produce a chain of amino acids—the polypeptide—as the end product of translation.
Translation Produces the Building Blocks of Life
Mutations01:39

Mutations

Overview
Mutations01:35

Mutations

Mutations are changes in the sequence of DNA. These changes can occur spontaneously or they can be induced by exposure to environmental factors. Mutations can be characterized in a number of different ways: whether and how they alter the amino acid sequence of the protein, whether they occur over a small or large area of DNA, and whether they occur in somatic cells or germline cells.
Chromosomal Alterations Are Large-Scale Mutations
While point mutations are changes in a single nucleotide in...
Single Nucleotide Polymorphisms-SNPs01:05

Single Nucleotide Polymorphisms-SNPs

A single nucleotide polymorphism or SNP is a single nucleotide variation at a specific genomic position in a large population. It is the most prevalent type of sequence variation found in the human genome. Point mutations that occur in more than 1% of the population qualify as SNPs. These are present once every 1000 nucleotides on an average in the human genome. Replacement of a purine with another purine (A/G) or a pyrimidine with another pyrimidine (C/T) is known as a transition. In contrast,...